Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update

Go back to Kyntra Bio Reports First Quarter 2026 Financial Results and Provides Business Update
(NASDAQ: KYNB) Delayed: 7.13 +0.37 (5.47%)
Previous Close $6.76    52 Week High
Open $6.80    52 Week Low
Day High $7.95    P/E N/A 
Day Low $6.72    EPS
Volume 461,353